AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycicheck MV 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Astorion Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glycicheck MV 2mg/500mg/0.2mg Tablet

Diabexe Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic agents, a combination medication for adult type 2 diabetes mellitus management. This formulation assists in regulating blood glucose. Diabexe Trio should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals and carry a readily available fast-acting glucose source (e.g., sugary snacks, fruit juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencement. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended by your doctor.

Primary Ingredients of Glycicheck MV 2mg/500mg/0.2mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Glycicheck MV 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Glycicheck MV 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glycicheck MV 2mg/500mg/0.2mg tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.

Common Side effects of Glycicheck MV 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glycicheck MV 2mg/500mg/0.2mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Glycicheck MV 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption should occur on an empty stomach.

How Glycicheck MV 2mg/500mg/0.2mg Tablet works:

Glycicheck MV tablets (2mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glycicheck MV 2mg/500mg/0.2mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glycicheck MV 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glycicheck MV 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Individuals with kidney impairment should likely avoid Glycicheck MV 2mg/500mg/0.2mg Tablets due to potential safety concerns. A physician's consultation is advised. Moreover, this medication is unsuitable for patients experiencing severe kidney disease.

LiverLiverCAUTION

Patients with liver disease should use Glycicheck MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver impairment, initiation should be at a low dose; the medication is contraindicated in patients with severe liver disease.

What if you forget to take Glycicheck MV 2mg/500mg/0.2mg Tablet :

Should you forget a Glycicheck MV 2mg/500mg/0.2mg Tablet dose, administer it promptly. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glycicheck MV 2mg/500mg/0.2mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Glycicheck MV 2mg/500mg/0.2mg Tablet

Glycicheck MV 2mg/500mg/0.2mg tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation treats type 2 diabetes mellitus in adults. It helps regulate blood sugar when combined with a healthy diet and exercise. Glimepiride stimulates insulin secretion from the pancreas. Metformin reduces hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal blood glucose. This medication is unsuitable for type 1 diabetes.
Patients taking Glycicheck MV 2mg/500mg/0.2mg Tablets may experience side effects including low blood glucose, nausea, diarrhea, taste disturbances, gas, abdominal pain, headache, skin eruptions, and respiratory illness.
Glycicheck MV 2mg/500mg/0.2mg Tablets are contraindicated in individuals with hypersensitivity to any constituent or inactive ingredient. This medication should also not be administered to patients exhibiting moderate to severe renal impairment, or those with inflammatory bowel disease, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Glycicheck MV 2mg/500mg/0.2mg Tablet is inadvisable. This combination may exacerbate hypoglycemia and heighten the risk of lactic acidosis.
Indeed, Glycicheck MV 2mg/500mg/0.2mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is strongly advised.
Retain this medication within its original, sealed packaging. Follow the storage directions provided on the package or label. Discard any leftover medicine. Prevent access by children, pets, and others.
Glycicheck MV 2mg/500mg/0...
185
MRP 225
17% off